V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015628 | 160007737 | 1.72 | 114.1 | Palliative (P) | 2017-06-30 | 2017-07-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101653004 |
| 160015631 | 160007738 | 1.78 | 54.7 | Palliative (P) | null | 2016-05-14 | Cisplatin + Pemetrexed | 02 | N | LIPOSOMAL DOXORUBICIN | 100973029 |
| 160015633 | 160007739 | 1.71 | 69.5 | Curative (C) | 2017-03-23 | 2017-03-25 | Trial Unspecified | N | null | TRIAL UNSPECIFIED | 101163283 |
| 160015635 | 160007740 | null | null | Palliative (P) | 2016-02-17 | 2016-02-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101821525 |
| 160015638 | 160007741 | 1.58 | 2.8 | null | 2018-11-07 | 2018-11-26 | CARBOPLATIN | N | null | CARBOPLATIN | 100122317 |
| 160015641 | 160007742 | 1.84 | 67.6 | Curative (C) | 2016-12-10 | 2016-12-10 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100324209 |
| 160015642 | 160007743 | 1.76 | 101 | null | 2017-09-19 | 2017-09-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100560198 |
| 160015643 | 160007744 | 1.62 | 70 | Palliative (P) | 2019-03-23 | 2019-04-20 | Trial Unspecified | 02 | null | DOXORUBICIN | 100398069 |
| 160015645 | 160007745 | 1.62 | 52.6 | Palliative (P) | 2018-09-02 | 2018-09-07 | Erlotinib | 02 | N | EW EUROEWING 2012 ARM A VAC | 101040941 |
| 160015646 | 160007746 | 1.72 | 79.5 | Palliative (P) | 2016-11-08 | 2016-11-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100571836 |
| 160015647 | 160007747 | 1.68 | 61 | Palliative (P) | 2016-05-06 | 2016-06-06 | EURAMOS TRIAL | 02 | Y | CHOP R | 100852246 |
| 160015649 | 160007748 | 1.64 | 61.3 | Palliative (P) | 2017-05-02 | 2017-05-02 | Doxorubicin 75mg/m2 | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101367500 |
| 160015651 | 160007749 | 0 | 58 | Palliative (P) | null | 2018-12-31 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101700481 |
| 160015653 | 160007750 | 165 | 49.9 | Curative (C) | 2018-06-10 | 2018-06-19 | Cisplatin + Pemetrexed | 02 | N | CARBOPLATIN + PACLITAXEL | 100734431 |
| 160015659 | 160007751 | 1.58 | 55.6 | Palliative (P) | 2017-10-24 | 2017-10-24 | Doxorubicin + Olaratumab | 2 | N | BEVACIZUMAB | 101513351 |
| 160015661 | 160007752 | 1.79 | 62 | Palliative (P) | 2018-07-13 | 2018-08-09 | ICON8B TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101159988 |
| 160015663 | 160007753 | null | null | Palliative (P) | 2017-06-15 | 2017-06-24 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100567330 |
| 160015664 | 160007754 | 1.71 | 77.3 | Palliative (P) | 2017-04-03 | 2017-04-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101424782 |
| 160015665 | 160007755 | null | null | Palliative (P) | 2019-12-19 | 2020-01-08 | Doxorubicin + Olaratumab | 02 | null | NOT MATCHED | 100982713 |
| 160015668 | 160007756 | 1.57 | 65 | Neo-adjuvant (N) | 2019-11-09 | 2019-11-09 | Carboplatin + Paclitaxel (weekly) | N | null | CARBOPLATIN + PACLITAXEL | 100977993 |
| 160015669 | 160007757 | 1.53 | 116 | null | 2017-01-02 | 2017-01-04 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101035218 |
| 160015674 | 160007758 | 1.55 | null | Palliative (P) | 2017-12-22 | 2017-12-30 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101505571 |
| 160015677 | 160007760 | 1.93 | 107.6 | Palliative (P) | 2017-06-18 | 2017-07-09 | Ifosfamide | 02 | N | TRIAL | 100005753 |
| 160015678 | 160007761 | 1.7 | 88.4 | Palliative (P) | 2017-04-06 | 2017-04-21 | Doxorubicin + Ifosfamide | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100269210 |
| 160015679 | 160007762 | 1.78 | 78.35 | Palliative (P) | 2017-06-07 | 2017-06-07 | Doxorubicin 75mg/m2 | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100494943 |
| 160015680 | 160007763 | 1.69 | 80 | Palliative (P) | 2017-08-29 | 2017-10-15 | Pemetrexed | 01 | null | ETOP 13-18 BEAT-MESO TRIAL | 100092291 |
| 160015681 | 160007764 | 1.71 | 77.5 | Palliative (P) | 2018-09-22 | 2018-10-04 | DACARBAZINE + DOXORUBICIN | 02 | N | DOXORUBICIN + OLARATUMAB | 100563655 |
| 160015684 | 160007765 | 1.8 | 74.6 | Palliative (P) | 2017-03-08 | 2017-03-15 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | LIPOSOMAL DOXORUBICIN | 101515064 |
| 160015686 | 160007766 | 1.66 | 85.55 | Palliative (P) | 2016-12-27 | 2017-01-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101164878 |
| 160015689 | 160007767 | 1.64 | 66.2 | null | 2018-12-06 | 2018-12-08 | Rituximab | 02 | Y | NOT MATCHED | 101092894 |
| 160015693 | 160007768 | null | null | Adjuvant (A) | 2017-05-20 | 2017-05-24 | Trial Unspecified | 01 | null | ETOPOSIDE + IFOSFAMIDE | 100430511 |
| 160015696 | 160007769 | 1.68 | 54.4 | null | 2020-05-06 | 2020-05-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100650157 |
| 160015697 | 160007770 | 1.61 | 70 | null | 2017-09-06 | 2017-09-10 | Gemcitabine day 1&8 | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101271254 |
| 160015698 | 160007771 | 1.7 | 69.9 | Curative (C) | 2018-06-13 | 2018-06-27 | Doxorubicin + Ifosfamide | null | N | CISPLATIN + DOXORUBICIN | 101424905 |
| 160015699 | 160007772 | 1.72 | 75.7 | Palliative (P) | 2016-12-06 | 2016-12-27 | Trial Unspecified | N | null | TRIAL UNSPECIFIED | 100761742 |
| 160015700 | 160007773 | null | 11.8 | Neo-adjuvant (N) | 2018-05-02 | 2018-05-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100400047 |
| 160015701 | 160007774 | 1.7 | 87 | 03 | 2019-03-22 | 2019-04-18 | EURO-EWING | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100975326 |
| 160015703 | 160007775 | 1.63 | 53.4 | Neo-adjuvant (N) | 2016-06-20 | 2016-06-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100934751 |
| 160015704 | 160007776 | 1.56 | 69.9 | Palliative (P) | 2018-06-27 | 2018-06-27 | ETOP 13-18 BEAT-meso Trial | 02 | N | MAP | 100066090 |
| 160015705 | 160007777 | null | null | Palliative (P) | 2019-09-09 | 2019-09-09 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101788647 |
| 160015706 | 160007778 | 1.74 | 79 | null | 2018-11-19 | 2018-12-15 | Trial Unspecified | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100325480 |
| 160015709 | 160007779 | 1.58 | 74 | null | 2018-05-25 | 2018-06-19 | VIDE | null | N | DOXORUBICIN | 101579069 |
| 160015710 | 160007780 | 1.67 | 65.2 | Curative (C) | 2019-07-24 | 2019-07-31 | Carboplatin AUC 2 - 5 | null | N | CARBOPLATIN | 100023699 |
| 160015712 | 160007781 | 1.56 | 48.4 | Palliative (P) | 2019-02-08 | 2019-02-17 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100083795 |
| 160015721 | 160007782 | 1.65 | 80 | Palliative (P) | 2017-07-29 | 2017-08-11 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101287278 |
| 160015723 | 160007783 | 1.76 | 107.9 | Palliative (P) | 2019-01-28 | 2019-01-29 | IMATINIB | N | N | NB HRNBL-1 COJEC IND COURSE B | 100776439 |
| 160015725 | 160007784 | 0 | 0 | Palliative (P) | 2019-06-13 | 2019-06-13 | CARBOPLATIN + ETOPOSIDE | 02 | N | NIVOLUMAB | 100456531 |
| 160015726 | 160007785 | null | 79.6 | Palliative (P) | 2016-02-27 | 2016-03-04 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100531820 |
| 160015727 | 160007786 | 1.6 | 59.7 | Palliative (P) | 2017-05-06 | 2017-05-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100830885 |
| 160015728 | 160007787 | 1.7 | 72.6 | Palliative (P) | null | 2017-12-12 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101252207 |